GHRP-6 (5mg Vial) Dosage Protocol

GHRP-6 (5 mg Vial) Dosage Protocol

Quickstart Highlights

GHRP-6 dosage protocols leverage this potent hexapeptide growth hormone secretagogue to stimulate natural GH release via the ghrelin receptor pathway[1]. By amplifying pulsatile GH secretion and raising IGF-1 levels, GHRP-6 supports enhanced muscle development, improved recovery, accelerated fat metabolism, and appetite stimulation[1][2]. Unlike exogenous GH, GHRP-6 preserves normal feedback loops without suppressing somatostatin[1]. This educational protocol outlines a three-times-daily subcutaneous approach using a practical dilution for clear insulin-syringe measurements.

  • Reconstitute: Add 2.5 mL bacteriostatic water → 2.0 mg/mL concentration.
  • Typical dose range: 100–300 mcg per injection, three times daily.
  • Easy measuring: At 2.0 mg/mL, 1 unit = 0.01 mL = 20 mcg on a U-100 insulin syringe.
  • Storage: Lyophilized: freeze at −20 °C (−4 °F); after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F); avoid freeze–thaw cycles.
GHRP-6 Vial

Dosing & Reconstitution Guide

Educational guide for reconstitution and three-times-daily dosing

Standard Protocol (2.5 mL = 2.0 mg/mL)

Phase Dose per Injection (mcg) Units (per injection) (mL)
Weeks 1–8 (Standard) 100 mcg 5 units (0.05 mL)
Weeks 1–8 (Moderate) 150 mcg 7.5 units (0.075 mL)
Weeks 1–8 (Advanced) 200–300 mcg 10–15 units (0.10–0.15 mL)

Frequency: Inject three times daily subcutaneously (Morning, Midday, Bedtime) to mimic natural pulsatile GH release[1]. Space injections at least 3–4 hours apart. Administer on an empty stomach (30+ minutes before eating) when possible, as elevated blood glucose may blunt GH response[3]. For ≤10-unit (≤0.10 mL) administrations, consider 30- or 50-unit insulin syringes for improved readability.

Reconstitution Steps

  1. Draw 2.5 mL bacteriostatic water with a sterile syringe.
  2. Inject slowly down the vial wall; avoid foaming.
  3. Gently swirl/roll until dissolved (do not shake).
  4. Label and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light.

Important: This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.

Supplies Needed

Plan based on an 8–12 week protocol with three-times-daily dosing at 100 mcg per injection (300 mcg/day total).

  • Peptide Vials (GHRP-6, 5 mg each):

    • 8 weeks (16.8 mg total) ≈ 4 vials
    • 12 weeks (25.2 mg total) ≈ 6 vials
  • Insulin Syringes (U-100, 30- or 50-unit preferred for precision):

    • Per week: 21 syringes (3/day)
    • 8 weeks: 168 syringes
    • 12 weeks: 252 syringes
  • Bacteriostatic Water (10 mL bottles): Use 2.5 mL per vial for reconstitution.

    • 8 weeks (4 vials): 10 mL → 1 × 10 mL bottle
    • 12 weeks (6 vials): 15 mL → 2 × 10 mL bottles
  • Alcohol Swabs: One for the vial stopper + one for the injection site each injection.

    • Per week: 42 swabs (2 × 3/day)
    • 8 weeks: 336 swabs → recommend 4 × 100-count boxes
    • 12 weeks: 504 swabs → recommend 6 × 100-count boxes
GHRP-6 Vial
View Supplier
Insulin Syringes
View Supplier
Bacteriostatic Water
View Supplier
Alcohol Pads
View Supplier

Protocol Overview

Concise summary of the three-times-daily regimen.

  • Goal: Stimulate natural pulsatile GH release to elevate IGF-1, supporting muscle growth, recovery, and metabolic function[1].
  • Schedule: Three subcutaneous injections daily for 8–12 weeks.
  • Dose Range: 100–300 mcg per injection (300–900 mcg total daily).
  • Reconstitution: 2.5 mL per 5 mg vial (2.0 mg/mL) for accurate unit measurements.
  • Storage: Lyophilized frozen; reconstituted refrigerated up to 28 days; avoid repeated freeze–thaw.

Dosing Protocol

Suggested three-times-daily approach.

  • Standard: 100 mcg TID (300 mcg/day) — well-documented to significantly raise GH/IGF-1[1].
  • Moderate: 150 mcg TID (450 mcg/day) for enhanced response.
  • Advanced: 200–300 mcg TID (600–900 mcg/day) — upper practical limit.
  • Timing: Morning, Midday, Bedtime; 3–4 hours apart; ideally on empty stomach.
  • Cycle Length: 8–12 weeks; consider 1–2 week break after 3 months.

Storage Instructions

Proper storage preserves peptide quality.

  • Lyophilized: Store at −20 °C (−4 °F) for long-term; 2–8 °C (35.6–46.4 °F) acceptable for weeks[8].
  • Reconstituted: Refrigerate at 2–8 °C (35.6–46.4 °F); use within 28 days with bacteriostatic water[9].
  • Allow vials to reach room temperature before opening to reduce condensation uptake.

Important Notes

Practical considerations for consistency and safety.

  • Use new sterile insulin syringes for each injection; dispose in a sharps container.
  • Rotate injection sites (abdomen, thighs, upper arms) to reduce local irritation.
  • Inject slowly; wait a few seconds before withdrawing the needle.
  • GHRP-6 typically induces strong appetite within 20–30 minutes post-injection[5].
  • Document daily dose and site rotation to maintain consistency.

How This Works

GHRP-6 binds to the ghrelin receptor (GHS-R1a) on pituitary somatotrope cells, triggering robust pulsatile GH secretion through G-protein and phospholipase C activation[1]. Unlike exogenous GH, GHRP-6 preserves normal hypothalamic–pituitary feedback without suppressing somatostatin, allowing natural GH tapering[1]. Studies demonstrate that GHRP-6 can restore GH responsiveness even in obese subjects with blunted secretion, producing GH surges roughly twice as large as GHRH alone[3]. When combined with GHRH analogs, the synergistic effect yields massive GH discharge far exceeding either peptide individually[3]. The peptide has a short half-life of approximately 20 minutes, necessitating multiple daily administrations[1].

Potential Benefits & Side Effects

Observations from preclinical and clinical literature.

  • Elevated GH/IGF-1: Consistent increases in circulating GH and IGF-1, supporting anabolic processes and body composition improvements[1][2].
  • Muscle and recovery: May enhance lean muscle mass, strength, and tissue repair through IGF-1 elevation[1].
  • Appetite stimulation: Pronounced ghrelin-mimetic hunger effect within 20–30 minutes post-injection; useful for cachexia or weight gain goals[5].
  • Sleep modulation: Studies show increased stage 2 sleep duration without major REM disruption[4].
  • Generally well tolerated: No serious adverse effects reported at moderate doses in human studies[1]. Mild injection-site reactions possible.
  • Transient hormonal effects: Brief elevation of ACTH and cortisol post-injection; usually clinically insignificant[4].

Lifestyle Factors

Complementary strategies for best outcomes.

  • Pair with a balanced, protein-forward diet tailored to energy needs.
  • Combine resistance training and aerobic activity to reinforce anabolic and metabolic adaptations.
  • Prioritize sleep quality—GH is naturally highest during deep sleep.
  • Administer on an empty stomach when possible to optimize GH response.
  • Be mindful of the appetite-stimulating effect if fat loss is a primary goal.

Injection Technique

General subcutaneous guidance from clinical best-practice resources[6][7].

  • Clean the vial stopper and skin with alcohol; allow to dry.
  • Pinch a skinfold; insert the needle at 45–90° into subcutaneous tissue[6].
  • Do not aspirate for subcutaneous injections; inject slowly and steadily[6].
  • Wait 5 seconds after injection before withdrawing the needle[7].
  • Rotate sites systematically (abdomen, thighs, upper arms) to avoid lipohypertrophy[7].

Important Note

This content is intended for therapeutic educational purposes only and does not constitute medical advice, diagnosis, or treatment.

References


  • PMC — The Safety and Efficacy of Growth Hormone Secretagogues
    — Comprehensive review of GHRP-6 mechanism, dosing, GH/IGF-1 effects, and safety profile
    View Source

  • PubMed — Pharmacokinetic study of GHRP-6 in healthy volunteers
    — Human pharmacokinetic data, dose-response, and tolerability at high doses
    View Source

  • PubMed — Massive GH discharge after combined GHRH and GHRP-6
    — Evidence for synergistic GH release and somatotroph secretory capacity in obesity
    View Source

  • PubMed — GHRP-6 stimulates sleep, GH, ACTH and cortisol in normal man
    — Human study on sleep architecture, stage 2 sleep, and transient hormonal effects
    View Source

  • PubMed — GHRP-6 mimics ghrelin-induced stimulation of food intake
    — Preclinical evidence for potent appetite-stimulating (orexigenic) action
    View Source

  • CDC — Vaccine Administration: Subcutaneous Injection
    — Technique guidance for subcutaneous route (angle, site, no aspiration)
    View Source

  • MedlinePlus — Giving an Insulin Injection
    — Patient instructions for subcutaneous technique, site rotation, and needle handling
    View Source

  • NIBSC — Peptide Storage Guidelines
    — Lyophilized peptide storage temperature recommendations and stability
    View Source

  • CDC — Safe Injection Practices for Multi-Dose Vials
    — 28-day use guidance for bacteriostatic water and multi-dose vials
    View Source

  • Bachem — Care and Handling of Peptides
    — Technical guidance on peptide reconstitution, storage, and stability
    View Source

  • PMC — Subcutaneous Drug Injection Review
    — Pharmacologic considerations of the subcutaneous administration route
    View Source

  • Pure Lab Peptides
    — GHRP-6 (5 mg) product page (quality and batch documentation)
    View Source